Cervavac
In News The Drugs Controller General of India (DCGI) granted market authorisation to Serum Institute of India (SII) to manufacture indigenously-developed India’s first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer. Presently India is fully dependent on foreign manufacturers for the HPV vaccine. About Cervavac qHPV vaccine CERVAVAC has demonstrated robust antibody response that is […]